Blog

  • ‘When I was a child, everyone used it’: woman blames Johnson & Johnson talc for her cancer | Johnson & Johnson

    ‘When I was a child, everyone used it’: woman blames Johnson & Johnson talc for her cancer | Johnson & Johnson

    It was Sue Rizzello’s husband who persuaded her to see a doctor, concerned about the bloating in her abdomen that was making her more and more uncomfortable. Rizzello, then in her late 40s, had assumed it was menopausal weight gain, but agreed to go to her GP. “A smart locum said, ‘There’s something wrong here’, and sent me for a blood test … And that saved my life.”

    It was the worst news: Rizzello had stage 3 ovarian cancer that had begun to spread. She would need to begin chemotherapy immediately and prepare for the complete removal of her uterus, ovaries, fallopian tubes and omentum, a procedure that would put her into immediate menopause.

    It was the summer of 2012 and her husband, a chef, was working at one of the Olympic venues in Windsor, near to their then home in Slough. For Rizzello, however, “that whole summer was a blur” of painful treatment, including a clinical trial that was so tough, she was told, that many others had been unable to see it through.

    Six months later, the marketing consultant was told her cancer had gone. “But I was never the same. It was massive. It was an earth-shaking experience that really shook my confidence to the core.”

    Rizzello, now 60, was lucky, but she does not believe her cancer was just “one of those things” – she believes it was caused by talc.

    Johnson & Johnson continued to sell its talc products in the UK until 2023. Photograph: Dan Peled/AAP

    She is one of about 3,000 British-based people – overwhelmingly women – who on Thursday brought a landmark legal action in the high court in London against the pharmaceuticals company Johnson & Johnson, claiming they or a family member contracted cancer after a lifetime using J&J’s baby powder.

    Backed by a specialist law firm, the claimants argue that the US-based multinational knew for decades that its talc products might contain dangerous asbestos but failed to warn consumers and carried on selling the products in the UK until 2023.

    J&J denies the allegations. A spokesperson for Kenvue, J&J’s former consumer health division that was spun off two years ago, said the talc used in baby powder complied with regulations, did not contain asbestos, and does not cause cancer.

    Rizzello says she was in the dark about the origin of her disease, after genetic tests showed she did not carry the BRCA genes that significantly increase the risk of ovarian cancer. “And then I found out about the talc claims, and I thought, hang on.”

    “I’ve used talc all my life. I mean, when I was a child, everybody did,” she says, whether after swimming or after a bath. “It was just always there. It was just always something you use.

    “I’m totally convinced this was the cause of my own illness, and all the nightmare of treatment and trials that followed.”

    J&J has been the subject of long-running lawsuits in the US over similar allegations of cancer links to talc, which it wholly disputes. Two years ago it spun off its consumer health division as Kenvue, which has responsibility for talc-related claims outside the US and Canada.

    Kenvue said: “We sympathise deeply with people living with cancer. We understand that they and their families want answers – that’s why the facts are so important.

    “The high-quality cosmetic-grade talc that was used in Johnson’s Baby Powder was compliant with any required regulatory standards, did not contain asbestos, and does not cause cancer.”

    Two years ago, to mark the 10-year anniversary of being given the all clear, Rizzello asked friends to sponsor her to shave her hair again to raise money for cancer charities, in memory of others with the disease who did not survive. “I felt I really had to do something,” she says. “Many of the women I’ve met along the way had died, and so I always feel like it’s for them as much as it is for me.

    “I value some things much more highly than I did before. I think I’ve always dreaded the idea of getting older. I don’t mind getting older now, and I’m so grateful to have a chance to get older.”

    Continue Reading

  • Pop-rock wizard Todd Rundgren: ‘When I met John Lennon, he was a bundle of rags with nothing to say’ | Todd Rundgren

    Pop-rock wizard Todd Rundgren: ‘When I met John Lennon, he was a bundle of rags with nothing to say’ | Todd Rundgren

    I Saw the Light is extraordinarily brilliant. How did you write it? Eamonmcc
    I was still learning about songwriting and by the time I got to Something/Anything? [1972, featuring I Saw the Light] I was slipping into formula – verse, chorus,…

    Continue Reading

  • Women’s health research funding in Canada across 15 years suggests low funding levels with a narrow focus | Biology of Sex Differences

    Women’s health research funding in Canada across 15 years suggests low funding levels with a narrow focus | Biology of Sex Differences

    In total, there were 775 project grants that received CIHR funding in 2023. Seven bridge grants were removed, leaving a total of 768 unique project grants that received a total of $651,948,708 in research funding. In 2023, the average project…

    Continue Reading

  • From poison to power: How lead exposure helped shape human intelligence

    From poison to power: How lead exposure helped shape human intelligence

    What made the modern human brain so different from that of our extinct relatives, such as Neanderthals? Researchers at the University of California San Diego School of Medicine, along with an international team, have discovered that ancient…

    Continue Reading

  • Philips Opens New Sustainable Global Headquarters in the Netherlands

    Philips Opens New Sustainable Global Headquarters in the Netherlands

    “At Philips, our purpose is clear. We develop innovations that create better care for more people around the world,” said Roy Jakobs, CEO of Royal Philips. “Healthcare systems everywhere face growing pressure, from rising demand to workforce shortages. Our role is to help clinicians, providers, and partners deliver high-quality, more sustainable care through technology that truly makes a difference. Our new global headquarters reflects who we are and how we work: open, collaborative, and focused on impact and patient safety. It’s designed to bring people together, inspire innovation, and strengthen our global relations. From here, we continue our mission to improve lives and help shape the future of healthcare worldwide.”

    Continue Reading

  • SignalChem’s Tau proteins in neurodegenerative research

    SignalChem’s Tau proteins in neurodegenerative research

    Normally, Tau proteins stabilize microtubules and support neuronal function, but in neurodegenerative diseases such as Alzheimer’s, they undergo abnormal changes that lead to aggregation and the creation of neurofibrillary tangles (NFTs).

    These…

    Continue Reading

  • Fans remember Liam Payne in Wolverhampton a year after he died

    Fans remember Liam Payne in Wolverhampton a year after he died

    Rachael Lewisin Wolverhampton and

    Andrew DawkinsWest Midlands

    BBC Picture tributes are on the right of this photo attached to railings. Other tributes are also attached on the middle and left of this image.BBC

    Tributes were left on railings at West Park in Wolverhampton on Thursday

    Fans have been paying tribute to the singer Liam Payne in his home city of Wolverhampton a year after his…

    Continue Reading

  • WHO. Global technical strategy for malaria 2016–2030 [Internet]. Geneva, World Health Organization; 2015 [cited 2024 Dec 9]. Available from: https://iris.who.int/handle/10665/176712

  • Moonasar D, Nuthulaganti T, Kruger PS, Mabuza A, Rasiswi ES,…

Continue Reading

  • Identification of the Anopheles marshallii group and vector species composition in the forest ecozone of Akwa Ibom State, Southern Nigeria | Malaria Journal

    Identification of the Anopheles marshallii group and vector species composition in the forest ecozone of Akwa Ibom State, Southern Nigeria | Malaria Journal

    There is a wide array of anopheline mosquitoes capable of transmitting malaria in Africa, and each species has varied behaviours, distribution, and seasonality that influences their roles in malaria transmission [25]. For vector control to be…

    Continue Reading

  • Italian news publishers demand investigation into Google’s AI Overviews | Artificial intelligence (AI)

    Italian news publishers demand investigation into Google’s AI Overviews | Artificial intelligence (AI)

    Italian news publishers are calling for an investigation into Google’s AI Overviews, arguing that the search engine’s AI-generated summaries feature is a “traffic killer” that threatens their survival.

    FIEG, the Italian federation of newspaper publishers, said it has submitted a formal complaint to Agcom, Italy’s communications watchdog.

    Similar complaints have been filed in other EU countries. Coordinated by the European Newspaper Publishers’ Association, the aim is to push the European Commission to open an investigation against Google under the EU Digital Services Act.

    The threat posed by AI Overviews, which gives users information without them having to click through to the original source by summarising searches with a block of text at the top of the results page, is among the main concerns of European news outlets.

    FIEG said it was also worried about the more recent AI Mode, which takes information from multiple sources and presents them as a chatbot.

    The federation argues that the Google services “violate fundamental provisions of the digital services act, with detrimental effects on Italian users, consumers and businesses”.

    “Google is becoming a traffic killer,” FIEG said in a statement, adding that the products not only directly compete with content produced by publishing firms, but also “reduces their visibility and discoverability, and thus their advertising revenues”.

    “This has serious consequences for the economic sustainability and diversity of the media, with all the risks associated with a lack of transparency and the proliferation of disinformation in democratic debate,” the statement said.

    A study published in July by the UK-based Authoritas analytics company claimed AI Overviews, launched by Google last year, caused up to 80% fewer clickthroughs. The research, which was submitted as part of a legal complaint to the UK’s competition watchdog about the impact of Google AI Overviews, also found that links to YouTube – owned by Google’s parent company Alphabet – were more prominent compared with the normal search result system.

    A second study by the Pew Research Center, a US thinktank, also showed a big hit to referral traffic from Google AI Overviews, with users only clicking a link under an AI summary once every 100 times.

    Google claimed the studies were inaccurate and based on flawed methodology.

    Google AI Overviews arrived in Italy in March. In September, the country became the first in the EU to approve a comprehensive law regulating the use of artificial intelligence, including limiting child access and imposing prison terms on those who use the technology to cause harm, such as generating deepfakes.

    Giorgia Meloni’s government described the legislation, which aligns with the EU’s landmark AI Act, as a decisive move in influencing how AI is used across Italy.

    Continue Reading